Padmanabh P. Bhatt, Ph.D., currently holds the position of Senior Vice President, Intellectual Property, and Chief Scientific Officer at Supernus Pharmaceuticals, Inc. Dr. Bhatt has been an integral part of Supernus since its inception, contributing significantly to the company's growth and success in the pharmaceutical industry. With a Ph.D. in Pharmaceutics from the University of Rhode Island, Dr. Bhatt's expertise lies in drug delivery systems, formulation development, and intellectual property management. His extensive knowledge and experience have been crucial in steering Supernus' research and development efforts, particularly in the area of central nervous system disorders. Throughout his career, Dr. Bhatt has been recognized for his innovative approach to drug development and his ability to navigate complex intellectual property landscapes. He has been instrumental in the development and commercialization of several of Supernus' key products, including Trokendi XR and Oxtellar XR, which have significantly impacted the treatment of epilepsy. His leadership has also been vital in advancing the company's pipeline of novel therapies, ensuring that Supernus remains at the forefront of pharmaceutical innovation. In his dual role as Senior Vice President of Intellectual Property and Chief Scientific Officer, Dr. Bhatt oversees the strategic direction of Supernus' intellectual property portfolio and scientific research initiatives. He works closely with cross-functional teams to identify and protect new inventions, while also guiding the company's research efforts to address unmet medical needs. His dedication to advancing scientific knowledge and his commitment to improving patient outcomes have solidified his reputation as a respected leader in the pharmaceutical industry.